# Chronic Myeloid Leukemia Treatments

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/chronic-myeloid-leukemia-treatments-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 958,053 |
| Description | This cluster of papers focuses on the efficacy and resistance of various tyrosine kinase inhibitors, such as Imatinib, Dasatinib, and Nilotinib, in the treatment of Chronic Myeloid Leukemia (CML). The papers discuss molecular mechanisms of resistance, mutation analysis, leukemia stem cells, treatment discontinuation, and long-term outcomes of different targeted therapies. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | https://openalex.org/T11215 |
| Works | 67,544 |

## Topic researchers

Showing 12 of 20.

- [Stacey Gabriel](https://scholariq.org/researchers/stacey-gabriel/)
- [Robert Tibshirani](https://scholariq.org/researchers/robert-tibshirani/)
- [Guido Kroemer](https://scholariq.org/researchers/guido-kroemer/)
- [Gad Getz](https://scholariq.org/researchers/gad-getz/)
- [Elaine R. Mardis](https://scholariq.org/researchers/elaine-r-mardis/)
- [Shizuo Akira](https://scholariq.org/researchers/shizuo-akira/)
- [Todd R. Golub](https://scholariq.org/researchers/todd-r-golub/)
- [Matthew Meyerson](https://scholariq.org/researchers/matthew-meyerson/)
- [Hagop M. Kantarjian](https://scholariq.org/researchers/hagop-m-kantarjian/)
- [Gordon B. Mills](https://scholariq.org/researchers/gordon-b-mills/)
- [Richard K. Wilson](https://scholariq.org/researchers/richard-k-wilson/)
- [Marco A. Marra](https://scholariq.org/researchers/marco-a-marra/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.